171 related articles for article (PubMed ID: 6525148)
1. Antibody-independent killing of gram-negative bacteria via the classical pathway.
Clas F; Loos M
Behring Inst Mitt; 1984 Nov; (76):59-74. PubMed ID: 6525148
[TBL] [Abstract][Full Text] [Related]
2. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria.
Clas F; Euteneuer B; Stemmer F; Loos M
Behring Inst Mitt; 1989 Jul; (84):236-54. PubMed ID: 2552981
[TBL] [Abstract][Full Text] [Related]
3. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
Clas F; Loos M
Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034
[TBL] [Abstract][Full Text] [Related]
4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
5. Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.
Clas F; Loos M
Infect Immun; 1982 Sep; 37(3):935-9. PubMed ID: 6752030
[TBL] [Abstract][Full Text] [Related]
6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
7. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
[TBL] [Abstract][Full Text] [Related]
8. Antibody-independent interactions between Escherichia coli J5 and human complement components.
Betz SJ; Isliker H
J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.
Schweinle JE; Hitchcock PJ; Tenner AJ; Hammer CH; Frank MM; Joiner KA
J Clin Invest; 1989 Feb; 83(2):397-403. PubMed ID: 2492308
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
11. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
12. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
13. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor.
Ji YH; Fujita T; Hatsuse H; Takahashi A; Matsushita M; Kawakami M
J Immunol; 1993 Jan; 150(2):571-8. PubMed ID: 8419490
[TBL] [Abstract][Full Text] [Related]
14. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
15. Immune complex mediated activation of the classical complement pathway.
Borsos T
Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
[TBL] [Abstract][Full Text] [Related]
16. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
17. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
Loos M; Thesen R
J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
[TBL] [Abstract][Full Text] [Related]
18. The role of complement and antibodies in the impaired bactericidal activity of neonatal sera against gram-negative bacteria.
Jankowski S
Acta Microbiol Pol; 1995; 44(1):5-14. PubMed ID: 7660858
[TBL] [Abstract][Full Text] [Related]
19. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
